Wave Life Sciences Overview
Latest P/E ratio for Wave Life Sciences: -5.6 — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow-5.60
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
As of the most recent data, WVE shows a P/E ratio of -5.6. That is below the Healthcare sector average of 26.36. Scroll down for historical charts and peer comparison views.
The Healthcare sector average P/E ratio is about 26.36. Wave Life Sciences is at -5.6, which is lower that average. That is roughly 121.2% below the sector mean. Use the comparison chart on this page to see how WVE stacks up against individual peers as well.
Investors watch WVE's P/E ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Wave Life Sciences's latest reading is -5.6. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.
Besides this p/e ratio page, Stockcircle has Wave Life Sciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect P/E ratio (currently -5.6) with ownership activity and broader fundamentals.
The Healthcare average P/E ratio is about 26.36, while WVE is at -5.6. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
